Phosphoric Acid

Phosphoric Acid

SCHEMBL8972786

O.O.O.O.O.O.O.O=P([O-])(O)O.[Na+]

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.73
KDM4E B2RXH2 2/20 0.47
CYP2C19 P33261 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 2/20 0.47
CA2 P00918 1/20 0.39
CA1 P00915 2/20 0.37
CA4 P22748 2/20 0.37
CA5A P35218 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
MMP2 P08253 1/20 0.33
THRB P10828 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
FDPS P14324 1/20 0.33
BLM P54132 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL4601512 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL28894407 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL724055 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL28979871 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL101070 1.00
Phosphoric Acid SCHEMBL653726 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL40491 1.00
Phosphoric Acid SCHEMBL14656197 1.00 SLC34A1 (0.73) SLC34A1KDM4ECYP2C19KMT2ALMNA
Phosphoric Acid SCHEMBL4731817 1.00
Phosphoric Acid SCHEMBL23091295 0.95 SLC34A1 (0.67) SLC34A1KDM4ECYP2C19KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257291-A1 PARTICULATE LAUNDRY SCENT ADDITIVE COMPRISING A PERFUME/WATER-SOLUBLE POLYMER/SALT HYDRATE MATRIX PROCTER & GAMBLE (US) 2025-08-14 US claimed
US-12312567-B2 Particulate laundry scent additive comprising a polyethylene glycol/ethoxylated alcohol polymer composition THE PROCTER & GAMBLE COMPANY (US) 2025-05-27 US claimed
CN-117384849-A Novel human liver cancer tissue digestive juice and preparation method and application thereof 宁波长都生物科技有限责任公司 2024-01-12 CN claimed
CN-117205210-A Aqueous composition containing atropine 新加坡保健服务集团 2023-12-12 CN claimed
CN-117205209-A Aqueous composition containing atropine 新加坡保健服务集团 2023-12-12 CN claimed
CN-116660436-A Method for measuring DMTMM residual quantity in crosslinked sodium hyaluronate gel 上海昊海生物科技股份有限公司 2023-08-29 CN claimed
EP-4179129-A1 METHODS OF REMOVING DEPOSITS FROM A SURFACE USING A SALT FIELD OF THE INVENTION Angara Global Limited (RU) 2023-05-17 EP claimed
US-20230054402-A1 PARTICULATE LAUNDRY SCENT ADDITIVE THE PROCTER & GAMBLE COMPANY 2023-02-23 US claimed
WO-2022015186-A1 METHODS OF REMOVING DEPOSITS FROM A SURFACE USING A SALT FIELD OF THE INVENTION Angara Industries Ltd. (RU) 2022-01-20 WO claimed
WO-2021217171-A1 PARTICULATE LAUNDRY SCENT ADDITIVE THE PROCTER & GAMBLE COMPANY (US) 2021-10-28 WO claimed
EP-3901238-A1 PARTICULATE LAUNDRY SCENT ADDITIVE The Procter & Gamble Company (US) 2021-10-27 EP claimed
CN-103269687-A Bepotastine compositions ISTA PHARMACEUTICALS INC 2013-08-28 CN claimed
US-20250333667-A1 PARTICULATE LAUNDRY SCENT ADDITIVE INCLUDING A BUILDER PROCTER & GAMBLE (US) 2025-10-30 US disclosed
WO-2025226916-A1 PARTICULATE LAUNDRY SCENT ADDITIVE INCLUDING A BUILDER THE PROCTER & GAMBLE COMPANY (US) 2025-10-30 WO disclosed
EP-4630525-A1 LAUNDRY TREATMENT COMPOSITION INCLUDING A POLYALKYLENECARBONATE COMPOUND The Procter & Gamble Company (US) 2025-10-15 EP disclosed
US-20250312317-A1 ISOXAZOLINE PARASITICIDE FORMULATIONS AND METHODS FOR TREATING BLEPHARITIS TARSUS PHARMACEUTICALS, INC. 2025-10-09 US disclosed
CN-101098714-A Compositions comprising azelastine and methods of use thereof MEDPOINTE HEALTHCARE INC (US) 2008-01-02 CN disclosed
CN-1104912-C Compositions and methods for destroying hydrogen peroxide ADVANCED MEDICAL OPEICS CO (US) 2003-04-09 CN disclosed
EP-0702086-A1 Process for producing antibiotics F. HOFFMANN-LA ROCHE AG (CH) 1996-03-20 EP disclosed
US-4619778-A MIXTURE OF HYDRATED COMPOUND, FUSION TEMPERATURE DEPRESSING SALT, AND HYDROGEL IC GAS INTERNATIONAL LIMITED (GB) 1986-10-28 US disclosed